| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Amneal Pharmaceuticals, Inc. (AMRX) has 6 insiders with recent SEC Form 4 filings, including 10 buys and 0 sells. AMRX is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 291.0K | $4.69M | - | |
| Dir | 225.4K | $3.63M | - | |
| VP | 152.4K | $2.46M | - | |
| VP | 146.4K | $2.36M | - | |
| CFO | 122.2K | $1.97M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 28, 2019 | Nark Ted C | Director | Buy | 50,000 | $2.39 | $119,500.00 | +818.7% | |
| Aug 16, 2019 | Bhadauria Pradeep | SVP, Chief Scientific Officer | Buy | 30,000 | $2.41 | $72,300.00 | +400.0% | |
| Aug 7, 2019 | Boyer Andrew S | Exec VP, Comm Optns | Buy | 66,666 | $2.89 | $192,664.74 | +227.5% | |
| Aug 6, 2019 | Fosun International Ltd | 10% Owner | Buy | 327,000 | $2.91 | $951,570.00 | New | |
| Aug 5, 2019 | Fosun International Ltd | 10% Owner | Buy | 1,642,300 | $3.04 | $4,992,592.00 | New | |
| May 15, 2019 | Bhadauria Pradeep | SVP, Chief Scientific Officer | Buy | 7,000 | $8.48 | $59,360.00 | +1,400% | |
| May 13, 2019 | Boyer Andrew S | Exec VP, Comm Optns | Buy | 19,000 | $9.46 | $179,740.00 | +184.4% | |
| May 13, 2019 | Todisco Joseph76 | SVP, Specialty Commercial | Buy | 15,000 | $9.88 | $148,200.00 | +7.9% | |
| Mar 12, 2019 | Stewart Robert A | President And CEO | Buy | 17,000 | $11.92 | $202,640.00 | New | |
| Mar 12, 2019 | Bisaro Paul | Executive Chairman | Buy | 17,000 | $11.97 | $203,490.00 | New |